Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06007690
Status:
RECRUITING
Last Update Posted:
2024-05-06
First Post:
2023-08-17
Brief Title:
A Phase 3 Randomized Masked Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan AU-011 Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma
Sponsor:
Organization:
Aura Biosciences